Zhong Huijun, Rüsch Dirk, Forman Stuart A
Department of Anesthesia & Critical Care, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Anesthesiology. 2008 Jan;108(1):103-12. doi: 10.1097/01.anes.0000296074.33999.52.
The general anesthetic etomidate acts via gamma-aminobutyric acid type A (GABA(A)) receptors, enhancing activation at low GABA and prolonging deactivation. Azi-etomidate is a photo-reactive etomidate derivative with similar pharmacological actions, which has been used to identify putative binding sites. The authors examine the irreversible effects of azi-etomidate photo-modification on functional GABA(A) receptors in cell membranes.
GABA(A) receptors (alpha1beta2gamma2L) were expressed in both Xenopus oocytes and human embryonic kidney cells exposed to 365 nm light-activated azi-etomidate with or without GABA, then extensively washed. Receptor-mediated chloride currents were measured using voltage clamp electrophysiology to assess the ratio of peak responses at 10 microm and 1 mm GABA (I10/I1000) and deactivation time course.
After azi-etomidate photo-modification, I10/I1000 ratios were persistently enhanced and deactivation was prolonged, mimicking reversible azi-etomidate actions. Azi-etomidate and ultraviolet light were required to produce irreversible receptor modulation. Adding GABA during photo-modification greatly enhanced irreversible modulation. Azi-etomidate modification also dose-dependently reduced maximal GABA-activated currents, consistent with accumulation of permanently desensitized receptors. Excess etomidate during azi-etomidate photo-modification competitively reduced permanent desensitization. Persistent channel modulation was blocked by 320-fold excess etomidate but enhanced when 32-fold excess etomidate was present.
Azi-etomidate efficiently photo-modifies etomidate sites on GABA(A) receptors in intact cells, producing persistent functional changes that mimic its reversible effects. The results demonstrate sequential modification at more than one etomidate site per receptor. The sites display reciprocal positive cooperativity. In combination with focal photo-activation, azi-etomidate may prove useful for studies of anesthetic actions in neural circuits.
全身麻醉药依托咪酯通过γ-氨基丁酸A型(GABA(A))受体起作用,在低GABA水平时增强激活作用,并延长失活时间。氮杂依托咪酯是一种具有相似药理作用的光反应性依托咪酯衍生物,已被用于确定假定的结合位点。作者研究了氮杂依托咪酯光修饰对细胞膜中功能性GABA(A)受体的不可逆影响。
GABA(A)受体(α1β2γ2L)在非洲爪蟾卵母细胞和人胚肾细胞中表达,这些细胞暴露于365nm光激活的氮杂依托咪酯,有无GABA均可,然后充分洗涤。使用电压钳电生理学测量受体介导的氯离子电流,以评估10μM和1mM GABA时的峰值反应比率(I10/I1000)和失活时间进程。
氮杂依托咪酯光修饰后,I10/I1000比率持续增加,失活延长,类似于氮杂依托咪酯的可逆作用。需要氮杂依托咪酯和紫外线才能产生不可逆的受体调节。光修饰期间添加GABA可大大增强不可逆调节。氮杂依托咪酯修饰还剂量依赖性地降低最大GABA激活电流,这与永久性脱敏受体的积累一致。氮杂依托咪酯光修饰期间过量的依托咪酯竞争性地减少永久性脱敏。持续的通道调节被320倍过量的依托咪酯阻断,但当存在32倍过量的依托咪酯时增强。
氮杂依托咪酯可有效光修饰完整细胞中GABA(A)受体上的依托咪酯位点,产生模拟其可逆作用的持久功能变化。结果表明每个受体上不止一个依托咪酯位点发生顺序修饰。这些位点表现出相互的正协同性。与局部光激活相结合,氮杂依托咪酯可能对神经回路中麻醉作用的研究有用。